Cardiovascular Drug Matching

Edit Answers
123456789101112131415
Across
  1. 3. Antagonist at B1, B2, and alpha, may cause bronchoconstriction (decreases HR and SVR)
  2. 4. Venous and arteriolar vasodilator via NO
  3. 6. V1 receptor agonist (increases SVR)
  4. 7. Mainly venous dilator via NO, some arterial dilation
  5. 9. Phosphodiesterase inhibitor (increases intracellular Ca and CO, decreases SVR)
  6. 10. D1 agonist (low dose), B1 agonist (med dose), a1 agonist (high dose)
  7. 12. Antimuscarinic (increases HR)
  8. 13. B1 and B2 agonist (increases CO and decreases SVR)
  9. 14. Selective a1 agonist (increases SVR)
  10. 15. Causes release of norepinephrine, direct-acting effects (increases CO)
Down
  1. 1. B1 agonist, very small B2 agonism (increases CO)
  2. 2. Antimuscarinic, does not cross BBB
  3. 5. Rapid-onset, short-acting B1 antagonist
  4. 8. Agonist at B1, B2, a1, a2 (increases CO)
  5. 11. Agonist of B1, a1, and a2 (increases SVR)